Aliivosidenib

Aliivosidenib uses and dosage

Aliivosidenib (Ivosidenib), generic Tibsovo is a prescription medicine used to treat in combination with Ivosidenib and azacitidine for the treatment of newly diagnosed acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test in adult patients who are 75 years old or older or who have comorbidities that preclude use of intensive induction chemotherapy. Ivosidenib is also indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) and previously treated, locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Aliivosidenib is manufactured by Alliance Pharma Ltd. In Laos. Ivosidenib has to take 500mg (two tablets of 250mg) orally once daily with or without food until disease prog

Aliivosidenib side effects

The most common adverse reactions of IVOSIDENIB are: Diarrhea, nausea, vomiting, stomach/abdominal pain, constipation, mouth sores, decreased appetite, dizziness, lightheadedness, headache, or tiredness.

Originator brand

TIBSOVO by SERVIER

Made by

Alliance Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.